Bob More - Profile and Investment Details

Investor Profile

Bob More is a Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals, Chimerix, Sutro Biopharma, Larimar Therapeutics, Aegis Semiconductor, Esperion Therapeutics, Taligen Therapeutics, Coapt Systems, Tyra Biosciences, GenePeeks, Launchpad IX (Alta Partners), Bill & Melinda Gates Foundation, DispatchHealth, ChemoCentryxSunesis Pharmaceuticals, Intradigm Corporation, SurgRx, PneumRx, PatientsLikeMe, Cara Therapeutics, Immune Design, Sonexa Therapeutics, Trevena, Excaliard Pharmaceuticals, Xelerated, MacroGenics, St. George's University, SARcode Bioscience, Neothetics, Kite Pharma, Sierra Surgical, VertiFlex, Virobay, CymaBay Therapeutics, Allakos, EGenesis, ZS Pharma, Everside Health, Portola Pharmaceuticals, TransMedics, Aegerion Pharmaceuticals, Vir Biotechnology, Pathwork Diagnostics, MAKO Surgical, CuraSen Therapeutics, Aerovance, Achaogen, Evofem Biosciences, Aerie Pharmaceuticals, Be Biopharma, Anesiva, Kiadis Pharma, Carbylan Therapeutics, Applied Genetics Technologies Corporation, Variant Bio, Lumena Pharmaceuticals, Corcept Therapeutics, aTyr Pharma, Foldrx Pharmaceuticals, 7TM Pharma, Novome Biotechnologies, Qihan Biotech, . Over time, Bob More has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bob More is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Genetics, Wellness, Women Founded, Healthcare Innovation, Life Science, Medical Technologies, Information Services, Software, Biotechnology, Medical Devices, Genomics, Clinical Trials, Home Care, Gene Therapy, Telehealth, Digital Health, Medical, Information Technology, B2B, Therapeutics, Health Tech, Cellular Therapy, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Bob More, as their portfolio suggests a familiarity and interest in this area.

Understanding Bob More’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.